Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding.

Tang, Jian-Ying; Yang, Lu; Wang, Jing; Yang, Ying; Li, Jun-Chen; Mu, Jiao

Tang, Jian-Ying; Yang, Lu; Wang, Jing; Yang, Ying; Li, Jun-Chen; Mu, Jiao.

Afiliação

Tang JY; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Yang L; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Wang J; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Yang Y; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Li JC; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Mu J; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.

Clin Kidney J ; 17(7): sfae175, 2024 Jul.

Article em En | MEDLINE | ID: mdl-39021812

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Kidney J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google